Descriptif de l'entité et de l'activité Filiale du groupe Air Liquide, Pharma Dom assure depuis plus de 40 ans..., de nutrition, d'insulinothérapie par pompe, ou un équipement médical. Pharma Dom, sous sa marque Orkyn', est engagée dans...
Marchés de la Pharma/Biotech et Cosmétiques/Hygiène. Rejoindre une entreprise où vos valeurs comptent ! Entreprendre... sur les marchés Pharma & Cosmétique. Vos missions : Business/Process : Conception des outils de calcul destinés aux...
Title: Ingénieur Développement Analytique H/F - CDD 1 an Company: Ipsen Pharma Biotech (SAS... de médicaments innovants en oncologie, maladies rares et neurosciences. Ipsen Pharma Biotech est un site de fabrication de produits...
Intellect Design Arena's shares jumped 13% following enthusiasm for its new AI platform, Purple Fabric. The platform enhances enterprise operations and targets SMEs. Continue Reading »
Upcoming IPO: Indo Farm Equipment IPO subscription opens on December 31 and ends on January 2. Allocation for anchor investors is on December 30. The firm produces tractors and cranes, with a manufacturing facility in Himachal Pradesh, and plans to use IPO proceeds for expansion and debt repayment. Continue Reading »
Identical Brains Studios IPO GMP: According to market observers, shares of the company are available at a premium of ₹48 in the grey market today Continue Reading »
HDFC Bank's shares have delivered a modest return of 5.7% YTD, trailing the benchmark indices. In comparison, the Sensex has gained 8.6%, while the Nifty Bank index has posted a 6% increase during the same period. Continue Reading »
JM Financial has initiated coverage on Brainbees Solutions, recommending a 'buy' rating with a target price of ₹692 per share, highlighting its strong market presence and growth potential in the childcare sector. Continue Reading »
Stock Market Today: Reliance Idustries share price remains in a donwtrend having hit 1year lows on Friday. However the shares rebounded up to 1.5% on Monday. Here are 5 key reasons why Mirae Asset Sharekhan expects almost 50% upside for the stock Continue Reading »